US 12,710,424 · Application 18/262,316 · Granted Aug 18, 2026
US 12,710,424
An extraction process of pancrelipase and evaluation thereof
Estimated expiration
October 16, 2042
16y 41d remaining
- Could not fetch continuity data for application PCTIB2022052651: Resource not found (404)
Earliest effective filing
Mar 23, 2022
+ 20 years
Mar 23, 2042
PTA +207d
Oct 16, 2042
No TD
—
Final
Oct 16, 2042
This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included.
Calculation details
Base term
- Filing date
- July 20, 2023
- Earliest effective filing
- March 23, 2022
- Issue date
- August 18, 2026
- PTA
- +207 days
- Base expiry (before PTA)
- March 23, 2042
March 23, 2022 + 20 years = March 23, 2042 + 207 PTA days = October 16, 2042
- National stage entry of application PCTIB2022052651, filed Mar 23, 2022
Terminal disclaimers
Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated
The prosecution record for your AI
Application 18/262,316 · US 12,710,424
You have the date. Your AI can have the file.
PatentReply compiles the prosecution history behind US 12,710,424: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.
One public application a month is free. The first compile takes a few minutes.
Strategy and filing changes require your approval.
Permanent link
www.patentreply.ai/tools/patent-expiration/US12710424Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.